Lenalidomide‐Dexamethasone as an Effective and Well‐Tolerated Treatment Option for Refractory Rosai‐Dorfman‐Destombes Disease: A Clinical and Pharmacophenomic Study
A combined clinical and computational pharmacophenomic study from the Coastal Rare Inflammatory Diseases Program and Every Cure.
Authors
- Ashley Sutherland (ORCID: https://orcid.org/0009-0005-0734-1769)
- Erica A. Peterson
- Kenneth L. McClain (ORCID: https://orcid.org/0000-0003-0725-6263)
- Emily Leung (ORCID: https://orcid.org/0000-0001-6593-4865)
- David C. Fajgenbaum (ORCID: https://orcid.org/0000-0002-7367-8184)
- Mark Trinder (ORCID: https://orcid.org/0000-0001-8447-2897)
- Oussama Abla (ORCID: https://orcid.org/0000-0001-7446-6274)
- Julia Varghese (ORCID: https://orcid.org/0000-0002-4424-634X)
- Rebecca A. Harrison (ORCID: https://orcid.org/0000-0002-5689-8492)
- Jan Dutz (ORCID: https://orcid.org/0000-0003-3035-0522)
- Nicholas Ronald Fragola (ORCID: https://orcid.org/0000-0002-3049-6145)
- Shannon Jackson
- Elysha Vanderveer
- Xiaotian Julie You
- Luke Y. C. Chen
- Piotr Kaniewski
- Elliott W. Sharp
Institutions
- BC Cancer Agency (CA)
- Dalhousie University (CA)
- University of British Columbia (CA)
- Quest University Canada (CA)
- Hospital for Sick Children (CA)
- Nova Scotia Health Authority (CA)
- Samuel S. Fleisher Art Memorial (US)
- Translational Therapeutics (United States) (US)
- Children's Cancer Center (US)
- McGill University (CA)
Publication Details
- Journal
- American Journal of Hematology
- Published
- 2026-04-02
- DOI
- https://doi.org/10.1002/ajh.70309
- Citations
- 1
- Primary Topic
- Histiocytic Disorders and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 19.92
Funders
- Chan Zuckerberg Initiative
- Lyda Hill Philanthropies
- National Heart, Lung, and Blood Institute